Document is current

Any future updates will be listed below

Novel anti-HER2 nanobody-drug conjugates with enhanced penetration of solid tumor and BBB, reduced systemic exposure and superior antitumor efficacy

Crossref DOI link: https://doi.org/10.1038/s41401-025-01634-3

Published Online: 2025-08-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark